All Blogs

Oct 10, 2025

Over a decade after launching one of the first treatments for idiopathic pulmonary fibrosis, Boehringer Ingelheim is rejuvenating its presence in the rare lung disease arena with a newly approved therapy. On October 7, the FDA approved JASCAYD, marking the first new IPF treatment in over ten years. The approval fol...

Oct 09, 2025

Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe  On October 7, 2025, Vektor Medical, a leading innovator in cardiac arrhythmia care, received CE Mark approval for its vMap® System, a non-invasive, AI-powered technology that converts standard 12-lea...

Oct 08, 2025

The integration of Artificial Intelligence in clinical trials marks one of the most transformative shifts in modern drug development. As the pharmaceutical industry grapples with rising R&D costs, long trial timelines, and high attrition rates, AI in clinical trials has emerged as a catalyst for optimizing desi...

Oct 07, 2025

Aminex Therapeutics Secures FDA Orphan Drug Designation for AMXT 1501 + DFMO in Neuroblastoma Aminex Therapeutics, Inc., a clinical-stage biotechnology company developing novel cancer therapies, announced that the FDA has granted Orphan Drug Designation (ODD) to AMXT 1501 in combination with difluoromethylornith...

Oct 06, 2025

Traumatic brain injury should not be viewed solely as an acute condition; it can also manifest as a chronic disorder that adversely impacts quality of life and is associated with long-term health consequences. The development of services for TBI care can be guided by public health insights and policy awareness rega...

Oct 03, 2025

Ovarian cancer ranks among the most lethal gynecological cancers, largely because it is often detected at advanced stages and recurs frequently despite initial response to surgery and chemotherapy. Most cases are epithelial, with High-grade Serous Ovarian Cancer (HGSOC) being the most common and aggressive, typical...

Oct 01, 2025

Not long ago, the word wearable instantly brought to mind fitness trackers counting steps or smartwatches nudging users to stand up. While those devices sparked the early boom, the next chapter, Wearables 2.0, is unfolding at the intersection of healthcare and technology. Today, wearable medical devices are no long...

Oct 02, 2025

Zimmer Biomet Announced Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System  On September 25, 2025, Zimmer Biomet Holdings, Inc., a global leader in medical technology, announced that Japan’s Pharmaceutical and Medical Devices Agency (PMDA) had approved the iTaperloc® Complete a...

Sep 30, 2025

Regeneron’s EVKEEZA Wins FDA Approval for HoFH in Children as Young as 1 Year Regeneron Pharmaceuticals, Inc. announced that the FDA has approved EVKEEZA (evinacumab-dgnb) ANGPTL3 antibody, for children aged 1 to under 5 years with homozygous familial hypercholesterolemia (HoFH). This expands the indication from...

Sep 29, 2025

Affecting roughly 1–2 people per 100,000 each year, essential thrombocythemia is often silent, discovered during routine blood tests, yet it can quietly impact quality of life. The total number of diagnosed cases of essential thrombocythemia in the US was approximately 167,000 cases in 2024. In the United States, t...